Advertisement

Topics

ReNeuron Company Profile

02:06 EDT 18th June 2018 | BioPortfolio

ReNeuron stem cell transplantation biotechnology for brain cell therapeutics to promote recovery of function.

Location

Europoint Centre , 5-11 Lavington Street
London
SE1 ONZ
United Kingdom

Contact

Phone: 0207 928 1720
Fax: 0207 261 0268
Email: renmail@reneuron.com


News Articles [19 Associated News Articles listed on BioPortfolio]

ReNeuron Group (RENE) - The rise of the exosome

Edison Investment Research - Pharmaceutical & healthcare - ReNeuron Group: ReNeuron introduced its exosome nanomedicine programme at its recent capital markets day. While being a preclinical programme...

ReNeuron Group (RENE) - Biblical aspirations

Edison Investment Research - Pharmaceutical & healthcare - ReNeuron Group: ReNeuron’s interim results for the six months to 30 September 2017 showcased a crucial juncture in the company’s ...

ReNeuron Group (RENE) - Consolidation confusion?

Edison Investment Research - Pharmaceutical & healthcare - ReNeuron Group: ReNeuron’s recent 100 for 1 share consolidation was a benign and cosmetic ‘tidy up’ of its historical capit...

BRIEF—ReNeuron appoints new chief medical officer

UK cell-based therapies company ReNeuron today announced that Dr Richard Beckman has joined the company…

ReNeuron's CTX cells play a part in positive artificial nerve tissue study

This is the first time ReNeuron's CTX cells have been combined with an engineered support to guide nerve repair

ReNeuron pleased to secure podium presentation for stroke data at US conference

Michael Hunt, CFO at ReNeuron Group Plc (LON:RENE) tells Proactive positive long-term data on their CTX cell therapy for stroke has been presented at the American Heart Association International Str...

ReNeuron's Michael Hunt updates on product development

Michael Hunt, CFO at ReNeuron Group Plc (LON:RENE) chats to Proactive to update on the cell-based therapeutics specialist's research and development programmes. Hunt says they're to increase the n...

ReNeuron increases number of clinical sites in its PISCES III study

ReNeuron said it had taken the decision to increase the number of sites to ensure that patient recruitment targets in the study are met.

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

ReNeuron

ReNeuron stem cell transplantation biotechnology for brain cell therapeutics to promote recovery of function.

ReNeuron Group plc

ReNeuron Group plc is a leading player in the stem cell field, using human somatic stem cells to develop leading edge therapies for neurodegenerative and other diseases. We are also leveraging our ste...

More Information about "ReNeuron" on BioPortfolio

We have published hundreds of ReNeuron news stories on BioPortfolio along with dozens of ReNeuron Clinical Trials and PubMed Articles about ReNeuron for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ReNeuron Companies in our database. You can also find out about relevant ReNeuron Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Transplantation
Organ transplantation is the moving of an organ from one body to another or from a donor site to another location on the patient's own body, for the purpose of replacing the recipient's damaged or absent organ. The emerging field of regenerative ...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record